BMY
Bristol-Myers SquibbABOUT BMY
Bristol-Myers Squibb is a global biopharma company with strengths in oncology (Opdivo, Revlimid), cardiovascular (Eliquis), and immunology. The company acquired Celgene in 2019 for $74 billion and has been actively managing patent cliffs through pipeline development and bolt-on acquisitions.
WHY TRACK BMY ON SQUAWKFLOW
BMY put/call ratios are closely watched as the company navigates major patent expirations. Options flow around Eliquis and Revlimid loss-of-exclusivity dates signals institutional views on revenue replacement.
BMY DATA ON SQUAWKFLOW
Options Flow
Real-time BMY sweeps, blocks, and unusual options activity
Dark Pool Prints
Institutional BMY dark pool trades with size and sentiment
GEX Dashboard
BMY gamma exposure levels, call/put walls, and GEX flip
AI Narration
AI-powered analysis of BMY market microstructure in real time
News Sentiment
BMY news with AI sentiment scoring and impact analysis
Sector Context
Healthcare sector rotation and relative strength vs peers
Track BMY Live
Real-time options flow, GEX dashboard, dark pool alerts, and AI narration — free.
Open Terminal →LEARN MORE
A thorough explanation of implied volatility, how it is calculated, what it means, and how to use it in trading.
Max Pain Theory in Options: How It Works and Whether to Trust ItUnderstanding the max pain theory, how to calculate it, its track record, and practical ways to use it in your trading.